Neville Rex Edwards Fendall

Autor: Julie Lipscomb

Publikováno v: BMJ. 349:g4594-g4594

Neville Rex Edwards Fendall started his career in HM Overseas Medical Service in 1944. Initially in Nigeria, Malaya, and Singapore, he moved to Kenya with his wife, Doreen, in 1948; he subsequently became the …

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::db6fae990e89ddee9f8a283e7948ef27
https://doi.org/10.1136/bmj.g4594

The Pulmonary Fibrosis Foundation Patient Registry. Rationale, Design, and Methods

Autor: Ganesh Raghu, Steven D. Nathan, Kevin R. Flaherty, Kevin F. Gibson, Cindy Burg, Imre Noth, Mridu Gulati, Gregory P. Cosgrove, Bonnie R Wang, Jack Stauffer, Lisa Lancaster, Scott Staszak, Wendi R. Mason, Rex Edwards, Elizabeth A. Freiheit, Joao A. de Andrade, Bill Schmidt, Paul J. Wolters, Yicheng Ma, Cathie Spino, Kathleen O. Lindell

Publikováno v: Annals of the American Thoracic Society

Detailed understanding of longitudinal behavior, response to therapy, and applicable biomarkers for interstitial lung diseases (ILDs) is lacking. There is a need for a large multicenter registry that provides researchers and clinicians access to well

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::978676d00756146bcda8f15aac66029c
https://doi.org/10.1513/annalsats.202001-035sd

The Idiopathic Pulmonary Fibrosis Clinical Research Network (IPFnet)

Autor: Neil R. MacIntyre, R. Richardson, F. Stokes, David A. Lynch, Eric L. Eisenstein, J. Rochon, Marilyn K. Glassberg, D. Dahlgren, DA Lynch, David A. Zisman, P. J. Wolters, W. Tate, T. Gentry-Bumpass, Francis Cordova, K. Kinser, Craig S. Glazer, L. Brewster, Joao A. de Andrade, T. Perez, Gary M. Hunninghake, T. Haram, J. Estrom, Bethany B. Moore, Maria L. Padilla, J. Pesarchick, G. Rahimova, Thomas V. Colby, Kelli L. Cain, B. Schmetter, E. Yow, E. Calahan, J. A. Golden, M. L. Han, Kevin K. Brown, K. Hwang, J. Kaur, K. Meiras, James P. Utz, J.L. Myers, J. De Andrade, Naresh P. Patel, H. Y. Reynolds, Barry H. Gross, M. Stewart, R. Wehrmann, N. A. Ettinger, John S. Sundy, Danielle Antin-Ozerkis, Mark P. Steele, S. R. White, Ivan O. Rosas, Q. Yang, M. Schwarz, Jonas Román, Imre Noth, N. Sandbo, I. Garic, G. Berhanu, Maryl Kreider, Eric S. White, K. Baumann, M. Kallay, H. Reynolds, E. Lyda, Galen B. Toews, Margaret L. Snyder, Ella E. Kazerooni, Aditi Satti, G.J. Criner, Irene Swift, J. Winsor, Simon L.F. Walsh, P. Debrosse, C. Holm, Richard C. Becker, K. Huang, John E. Fitzgerald, H. R. Collard, Mitchell A. Olman, Wendi R. Mason, Tedryl Gentry-Bumpass, Andrew H. Limper, Sara B. Calvert, Gail Weinmann, T. E. King, R. J. Kaner, A. Eller, A. Demersky, Mary E. Strek, Steven A. Sahn, Susan Lubell, Jennifer Hayes, Mary Beth Scholand, K. West, C. Bair, Graham Jones, Rhonda Roberts, M. Vey, James E. Chapman, Paul Hofmann, K. Le, Daniel A. Culver, Harold R. Collard, James P. Kiley, V. Monroy, L. Sardin, Joseph D. Zibrak, A. Sharlow, N. O'Banner, T. Colby, T. Thomas, Victor J. Thannickal, S. Ditta, M. Ingham, K. Chan, A. Snydsman, R. Greer, A. Johnson, John A. Belperio, M. Han, Ganesh Raghu, Kevin R. Flaherty, C. Matti, D. Hill, Craig E. Daniels, Kevin J. Anstrom, S. Maleckar, P. Lopez, D. Whelan, Paul J. Wolters, Joseph P. Lynch, Marvin I. Schwarz, M. Wang, Linda Davidson-Ray, William Lawson, P. Berry-Bell, Aamer Chughtai, S. Merli, Jeffrey A. Golden, Joseph A. Lasky, D. K. Hogarth, J. Walker, Joao deAndrade, R. Anderson, S. Ramey, James E. Loyd, Jay H. Ryu, T. Nguyen, Rex Edwards, R. Kidd, Lake Morrison, P. Dignacco, R. Jeffrey, Lisa Lancaster, Robert J. Kaner, Robert C. Hyzy, K. Bandong, Dolly Kervitsky, J. McClelland, Fernando J. Martinez, E. Simonet, E. Kagan, C. Brown, J. Lynch, A. Meredith, R. Perez, X. Tian, M. Rossman, R. Beci

Publikováno v: Chest. 148:1034-1042

BACKGROUND The National Heart, Lung, and Blood Institute-sponsored IPF Clinical Research Network (IPFnet) studies enrolled subjects with idiopathic pulmonary fibrosis (IPF) to evaluate drug therapies in treatment trials. An adjudication committee (AC

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::51ebfbd141c37e6f6716ce4c7819bd32
https://doi.org/10.1378/chest.14-2889

Randomized Trial of Population-Based Clinical Decision Support to Facilitate Care Transitions

Autor: Eric L, Eisenstein, Janese M, Willis, Rex, Edwards, Kevin J, Anstrom, Kensaku, Kawamoto, Guilherme Del, Fiol, Fred S, Johnson, David F, Lobach

Publikováno v: Studies in health technology and informatics. 234

Medicaid beneficiaries in 6 North Carolina counties were randomly assigned to 1 of 3 clinical decision support (CDS) care transition strategies: (1) usual care (Control), (2) CDS messaging to patients and their medical homes (Reports), or (3) CDS mes

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b6438342c16bc515678a48d71810762c
https://pubmed.ncbi.nlm.nih.gov/28186023

Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: Does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials

Autor: Alan H. Kadish, Gillian D Sanders, Alfred E. Buxton, J. Thomas Bigger, Amy Laird, William J. Hall, Riccardo Cappato, Daniel B. Mark, Gust H. Bardy, Lurdes Y. T. Inoue, Rex Edwards, Jonathan P. Piccini, Paul Dorian, Al Hallstrom, Peter J. Kudenchuk, Arthur J. Moss, Paul L. Hess, Sana M. Al-Khatib, Richard C. Steinman, Kerry L. Lee

Publikováno v: Heart Rhythm. 10:828-835

Background Whether there is an optimal time to place an implantable cardioverter-defibrillator (ICD) more than 40 days after myocardial infarction (MI) in guideline-eligible patients is unknown. Objective To evaluate the effect of time from MI to ran

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ca19ce1f0b6e4d77baf6ccabb2d21b19
https://doi.org/10.1016/j.hrthm.2013.02.011